In contrast with the case of young mice, substantial increases in B220+ B cells and CD8+ and CD4+ T cells were detected in bronchoalveolar lavage fluid (BALF) of tumor-bearing aged mice, particularly when they were treated with anti–PD-L1 therapy (Figure 1, A and B). This evidence concerns the gene CD8A and neoplasm.